Glucagonoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 18: | Line 18: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Neurosurgery]] | [[Category:Neurosurgery]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 20:15, 21 August 2015
Glucagonoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Glucagonoma medical therapy On the Web |
American Roentgen Ray Society Images of Glucagonoma medical therapy |
Risk calculators and risk factors for Glucagonoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
- Heightened glucagon secretion can be treated with the administration of octreotide, a somatostatin analog, which inhibits the release of glucagon.[1]
- Doxorubicin and streptozotocin have also been used successfully to selectively damage alpha cells of the pancreatic islets. These do not destroy the tumor, but help to minimize progression of symptoms.
- The only curative therapy for glucagonoma is surgical resection, where the tumor is removed. Resection has been known to reverse symptoms in some patients.